# Long Acting Neuraxial Peri-prostatic Block in Cancer

> **NCT06703437** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 12 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Dehydrated alcohol
- **DRUG:** Lidocaine IV

## Key facts

- **NCT ID:** NCT06703437
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-12-13
- **Primary completion:** 2023-02-23
- **Final completion:** 2026-06-01
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2025-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06703437

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06703437, "Long Acting Neuraxial Peri-prostatic Block in Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06703437. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*